dpp-4 inhibitor and glp-1 receptor agonist combination Frontiers Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)

Protein turnover in skeletal muscle

SUD-N and SUD-M adopt a macrodomain fold, whereas SUD-C has a frataxinlike fold

24 weeks[1] Elderly patients: May respond better due to age-related carnitine deficiency[2] Patients with mitochondrial dysfunction: Strong mechanistic rationale for benefit[9] Early intervention: Better outcomes when started before severe nerve damage Cost-Effectiveness Strategies: Purchase larger quantities (90-180 count bottles) for volume discounts Generic products with third-party verification offer best value Consider powder formulations for significant cost savings Start at lower dose (1,500 mg/day) and increase only if needed Combine with other nutraceuticals to potentially reduce pharmaceutical costs Maximizing Bioavailability: Divide doses throughout the day (saturable absorption)[3] Consider initial IM loading in severe cases (500 mg BID 14 days) followed by oral maintenance[10] Take with food to improve tolerability without significantly affecting absorption Ensure adequate hydration CLINICAL DECISION-MAKING 1

Amino acids, such as L-carnitine, are under investigation for their role in energy production and symptom management, although results are mixed